AR032933A1 - Compuestos que contienen creatina y creatinina - Google Patents

Compuestos que contienen creatina y creatinina

Info

Publication number
AR032933A1
AR032933A1 ARP020100757A ARP020100757A AR032933A1 AR 032933 A1 AR032933 A1 AR 032933A1 AR P020100757 A ARP020100757 A AR P020100757A AR P020100757 A ARP020100757 A AR P020100757A AR 032933 A1 AR032933 A1 AR 032933A1
Authority
AR
Argentina
Prior art keywords
creatinine
creatin
compounds containing
composition
creatine
Prior art date
Application number
ARP020100757A
Other languages
English (en)
Spanish (es)
Inventor
Alan Norman Howard
Roger Charles Harris
Original Assignee
Howard Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0105205A external-priority patent/GB0105205D0/en
Priority claimed from US09/917,634 external-priority patent/US6524611B2/en
Application filed by Howard Foundation filed Critical Howard Foundation
Publication of AR032933A1 publication Critical patent/AR032933A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483—Gleditsia (locust)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
ARP020100757A 2001-03-02 2002-03-01 Compuestos que contienen creatina y creatinina AR032933A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0105205A GB0105205D0 (en) 2001-03-02 2001-03-02 Compositions containing creatine and creatinine
GB0117868A GB0117868D0 (en) 2001-03-02 2001-07-23 Compositions containing creatine and creatinine
US09/917,634 US6524611B2 (en) 1996-05-31 2001-07-31 Compositions containing creatine and creatinine

Publications (1)

Publication Number Publication Date
AR032933A1 true AR032933A1 (es) 2003-12-03

Family

ID=27256090

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100757A AR032933A1 (es) 2001-03-02 2002-03-01 Compuestos que contienen creatina y creatinina

Country Status (12)

Country Link
EP (1) EP1363509B1 (enExample)
JP (1) JP4975943B2 (enExample)
AR (1) AR032933A1 (enExample)
AT (1) ATE341948T1 (enExample)
AU (1) AU2002237395B2 (enExample)
CA (1) CA2438622C (enExample)
DE (1) DE60215312T2 (enExample)
DK (1) DK1363509T3 (enExample)
ES (1) ES2276912T3 (enExample)
GB (1) GB2387101B (enExample)
MX (1) MXPA03007757A (enExample)
WO (1) WO2002069740A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
DE10136076A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
DE10316666B4 (de) * 2003-04-10 2015-04-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin mit Kreatin und Coenzym Q10
CA2621365C (en) 2005-05-23 2012-09-04 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
JP2007209231A (ja) * 2006-02-08 2007-08-23 Japan Organo Co Ltd クレアチン含有食品組成物
DE102006050931A1 (de) * 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
CN104080448B (zh) * 2011-11-10 2018-02-13 西泽广久 肌酸组合物的摄取方法及在该摄取方法中使用的肌酸组合物以及使用所述肌酸组合物制成的含肌酸的药剂及食品
WO2016172148A1 (en) 2015-04-20 2016-10-27 Vireo Systems, Inc. Compositions and methods for neuroprotection and treatment of neurodegeneration
US20220287346A1 (en) 2019-08-23 2022-09-15 The Coca-Cola Company Stable creatine beverages
JP7149541B2 (ja) * 2020-03-31 2022-10-07 医療法人社団杉一会 男性不妊症における精子所見を改善するための経口摂取用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0797977B2 (ja) * 1987-04-21 1995-10-25 味の素株式会社 食品に煮干ダシの呈味を付与する方法
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6274161B1 (en) * 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US6168802B1 (en) * 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract

Also Published As

Publication number Publication date
DE60215312T2 (de) 2007-04-19
CA2438622A1 (en) 2002-09-12
ATE341948T1 (de) 2006-11-15
GB2387101A (en) 2003-10-08
HK1060262A1 (en) 2004-08-06
GB2387101B (en) 2005-08-17
WO2002069740A1 (en) 2002-09-12
EP1363509A1 (en) 2003-11-26
AU2002237395B2 (en) 2006-08-31
ES2276912T3 (es) 2007-07-01
DK1363509T3 (da) 2007-02-12
MXPA03007757A (es) 2004-03-16
EP1363509B1 (en) 2006-10-11
JP4975943B2 (ja) 2012-07-11
JP2004520060A (ja) 2004-07-08
GB0318249D0 (en) 2003-09-10
CA2438622C (en) 2009-10-06
DE60215312D1 (de) 2006-11-23

Similar Documents

Publication Publication Date Title
MXPA05008903A (es) Composiciones que contienen creatina, creatinina y metil xantina.
SV2002000520A (es) Derivados de pirazol ref. pcs10927aajr/bb
CR11283A (es) "composicion de liberacion sostenida y proceso para producirla"
WO2006044334A3 (en) Platelet-derived growth factor compositions and methods of use thereof
SV2002000512A (es) Interleuquina-2 estabilizada ref. msb-7267-sv
CY1113353T1 (el) Φαρμακοτεχνικη μορφη αντι-τνf-αλφα αντισωματος
NO982907D0 (no) Tyrosinderivater som <alfa>-v-integrininhibitorer
MXPA03005505A (es) Compuesto modafinilo y mezclas de ciclodextrina.
EA200200492A1 (ru) Растворы, содержащие эпинастин
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
ECSP034617A (es) Kit de repinotan
CY1106203T1 (el) Η χρηση της l-καρνιτινης και των αλκανοϋλο παραγωγων αυτης σαν ωσμωτικων παραγοντων σε διαλυματα για ιατρικη χρηση
DE69922211D1 (de) Reinigungslösung und ihre anwendung
GB2387101A (en) Compositions containing creatine and creatinine
AR010636A1 (es) COMPOSICION BIOCIDA ALQUIDICA, CONCENTRADO DE LA MISMA, FORMULACIoN DE RECUBRIMIENTO Y MÉTODO PARA ESTABILIZAR LA ACTIVIDAD BIOCIDA.
DE60207026D1 (de) Verwendung von Pantethein-Sulfonsäure und/oder deren Salzen als anti-radikal Agent
DE502004005491D1 (de) Herstellung und verwendung von 3-methylamino-1-(2-thienyl)-1-propanon
AU2001278709A1 (en) 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
CU23077A1 (es) Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
DE50106647D1 (de) Verwendung von ectoin oder ectoin-derivaten zur mundpflege
ATE410164T1 (de) Wässrige flüssige preparation von pranoprofen
NO20030820D0 (no) Anvendelse av vitamin D derivater som benresorpsjons inhibitorer
NO20055882L (no) Farmasoytiske formuleringer omfattende amoksicillin og klavulanat

Legal Events

Date Code Title Description
FG Grant, registration